KoreaTimes - Bio

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Business

Bio

Mon, May 29, 2023 | 21:11

HLB Cell produces extracellular matrix Hutrigel

HLB Cell produces extracellular matrix Hutrigel

HLB Cell, a subsidy of HLB Life Science, succeeded in producing an extracellular matrix that is rich in human basement membrane through a normal cell culture procedure, the cell therapy drug developer said Wednesday. The company said it will release the organoid biomaterial called Hutrigel, which is based on normal human cells, in the second quarter of the year.

Baek Byung-yeul | 2023-04-05 16:07

HLB's US subsidiary promotes efficacy of liver cancer drug Rivoceranib

HLB's US subsidiary promotes efficacy of liver cancer drug Rivoceranib

HLB, a global biopharmaceuticals company, said Thursday that its U.S. subsidiary Elevar Therapeutics announced the efficacy and safety of the Rivoceranib liver cancer drug at a biopharmaceutical symposium in Washington, D.C. This comes as part of the Korean biotech company's efforts to promote the drug ahead of applying for new drug application (NDA) with the U.S. Food and Dr...

Baek Byung-yeul | 2023-03-23 16:24

POSCO International to expand carbon capture biz in green energy push

POSCO International to expand carbon capture biz in green energy push

POSCO International said Tuesday it will nurture carbon capture and storage (CCS) as one of its future growth drivers as the trading company accelerates its expansion into green energy.

2023-03-21 11:32

Samsung Biologics seeks to expand partnerships in New York

Samsung Biologics seeks to expand partnerships in New York

Samsung Biologics will take part in 2023 DCAT Week, a global event in the bio and pharmaceutical industry, which will take place in New York from March 20 to 23, in a bid to seek more partnerships, the company said Thursday. Hosted by the Drug, Chemical & Associated Technologies Association (DCAT), DCAT Week has been a representative networking event in the pharmaceutical ind...

Baek Byung-yeul | 2023-03-16 16:05

Celltrion founder to return to management after 2 year-hiatus

Celltrion founder to return to management after 2 year-hiatus

Seo Jung-jin, founder and honorary chairman of Celltrion, may return to management after two years, on expectations he can save the biotechnology group that is facing growing business uncertainties, according to company officials, Friday.

Baek Byung-yeul | 2023-03-03 16:52

Kakao Healthcare to launch blood sugar managing app in Q3

Kakao Healthcare to launch blood sugar managing app in Q3

Kakao Healthcare, a subsidiary of internet company Kakao, revealed a detailed vision for digital healthcare, saying it will launch a blood sugar management app in the third quarter of this year, according to the CEO, Thursday. “Digital healthcare has emerged as a lucrative business,” Hwang Hee, CEO of Kakao Healthcare, said during a press conference at Kakao's building in Seo...

Baek Byung-yeul | 2023-03-02 16:22

Samsung Biologics hit by series of attempts to steal trade secrets

Samsung Biologics hit by series of attempts to steal trade secrets

Samsung Biologics has been grappling with a series of attempts to steal its trade secrets as competition is intensifying in contract-based drug development and manufacturing, according to police and industry officials, Monday. Incheon Metropolitan Police said one of Samsung Biologics' employees was arrested recently for attempting to take company data from a worksite without ...

Baek Byung-yeul | 2023-02-27 16:56

Will Medytox's legal win over Daewoong deal blow to Hugel?

Will Medytox's legal win over Daewoong deal blow to Hugel?

Medytox's legal win over Daewoong Pharmaceutical is expected to shake up the local botulinum toxin (BTX) market, as Medytox, Korea's first Botox developer, is also embroiled in a legal tussle with another competitor, Hugel in the United States, over the BTX strain used to manufacture the cosmetics treatment, according to the companies, Monday. On Friday, the Seoul District Co...

Baek Byung-yeul | 2023-02-13 16:45

Medytox wins botulinum toxin patent suit against Daewoong

Medytox wins botulinum toxin patent suit against Daewoong

Medytox won a lawsuit against Daewoong Pharmaceutical on Friday over a botulinum toxin (BTX or Botox) patent. The two companies had locked horns over the origin of BTX strain used to manufacture the cosmetic treatment. “Daewoong Pharmaceutical's Nabota was developed by stealing Medytox's botulinum toxin strains and manufacturing process,” the Seoul Central District Court said...

Baek Byung-yeul | 2023-02-12 16:29

HLB's anticancer drug wins approval in China

HLB's anticancer drug wins approval in China

HLB's anticancer drug Rivoceranib was approved to be used for first-line treatment for liver cancer in China, the Korean biotech company said Thursday. The company said China's National Medical Products Administration (NMPA) approved the combination therapy of Rivoceranib and Camrelizumab, an anticancer drug of China's Jiangsu Hengrui Medicine, as a first-line treatment for l...

Baek Byung-yeul | 2023-02-02 16:44

1 2 3 4 5 6 7 8 9

Top 10 Stories

1	ChatGPT: boon or bane for banking industry?

2	Korea walks fine line between US, China in chip war

3	Jeju-based shamanism researcher documents connection between humans, crows

4	Man arrested for opening airplane emergency exit during flight

5	Labor unions seek to attract migrant workers at shipyards

6	Half of medical tourists visiting Korea inspired by K-culture

7	Hyundai Steel receives EPD certification for low-carbon H-beam products

8	RAS KOREAPreserving memories at Cheongju City Archives

9	Mirae Asset holds ETF Rally 2023 for global expansion

10	Gov't moves to assist 3,400 Koreans stranded in typhoon-hit Guam

DARKROOM